Four insights:
1. Xiphos-ZF is the first implant developed from a new biomaterial called Zfuze.
2. Zfuze is a load-bearing biomaterial that evokes a pro-reparative macrophage phenotype rather than a pro-inflammatory phenotype.
3. Paul Kraemer, MD, of Indiana Spine Group in Carmel is set to perform the first spinal surgery with Xiphos-ZF.
4. DiFusion will launch Xiphos-ZF in the fourth quarter.
More articles on devices:
Orthofix reports $40.5M loss & more: 7 device company notes
Price transparency, value-based care & bundles: Altair Health CEO aims to drive change in spine
Stryker receives FDA clearance for 3D-printed expandable interbody device — 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
